DNA stock forecast
Our latest prediction for Ginkgo Bioworks Holdings Inc's stock price was made on the Feb. 3, 2023 when the stock price was at 2.06$.
In the short term (2weeks), DNA's stock price should underperform the market by -2.15%. During that period the price should oscillate between -9.03% and +6.55%.
In the medium term (3months), DNA's stock price should underperform the market by -6.83%. During that period the price should oscillate between -25.11% and +19.47%.
Get email alertsCreate a solid portfolio with DNA
About Ginkgo Bioworks Holdings Inc
Ginkgo Bioworks is building a platform to enable customers to program cells as easily as they can program computers. The company's cell programming platform enables the growth of biotechnology across diverse markets, from food to fragrance to pharmaceuticals.
At the moment the company generates 1577M USD in revenues.
On its last earning announcement, the company reported a loss of None$ per share.
The book value per share is 0.93$
Three months stock forecastFeb. 3, 2023
Financials
| Revenue USD | Gross Margin | Operating Income | Operating Margin | Net Income | Earnings Per Share | Dividends | Payout Ratio | Shares | Book Value Per Share | Operating Cash Flow | Cap Spending | Free Cash Flow |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1577M | 28.96% | -2001M | -126.82% | -2030M | - | - | - | 1648M | 0.93 | - | - | - |